InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
T+90 hit rate
28%
T+90 mean return
-10.1%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Murthy Mala, Chief Financial Officer. Officer active across 2 companies, notably Teladoc Health, Inc.. Aggregated, 23 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €182k. Activity tracked since 28 October 2021. The latest transaction was filed on 8 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations23 total
17,100 shares0Common StockSEC:0001722482-25-000150:0
12,652 sharesCommon StockSEC:0001477449-25-000044:0
36,933 sharesCommon StockSEC:0001477449-25-000035:0
3,369 sharesCommon StockSEC:0001477449-25-000020:0
2,641 sharesCommon StockSEC:0001628280-24-049797:0
2,641 sharesCommon StockSEC:0001477449-24-000193:0
2,641 sharesCommon StockSEC:0001477449-24-000155:0
8,477 shares0Common StockSEC:0001722482-24-000117:0
10,565 sharesCommon StockSEC:0001477449-24-000039:0
3,369 sharesCommon StockSEC:0001477449-23-000106:0
3,369 sharesCommon StockSEC:0001477449-23-000040:0
3,368 sharesCommon StockSEC:0001415889-23-009199:0
9,808 shares0Common StockSEC:0001722482-23-000119:0
7,438 shares@ US$25.911100.0% of flowCommon StockSEC:0001415889-23-004411:0
13,475 sharesCommon StockSEC:0001415889-23-004087:0
7,968 sharesCommon StockSEC:0001415889-22-007017:0
6,693 shares0Common StockSEC:0001722482-22-000128:0
1,215 shares0Common StockSEC:0001722482-22-000083:0
2,677 sharesCommon StockSEC:0001415889-22-002576:0
916 shares0Common StockSEC:0001722482-21-000250:0
916 shares0Common StockSEC:0001722482-21-000250
7,968 sharesCommon StockSEC:0001179110-21-007067:0
7,968 sharesCommon StockSEC:0001179110-21-007067
23 of 23 declarations
About Murthy Mala
Mala Murthy is the Chief Financial Officer at Teladoc Health, Inc. and Avantor, Inc. She is responsible for the financial management and strategy of these companies. Her role involves overseeing financial operations, budgeting, and performance analysis. Her expertise is crucial in ensuring the financial health and growth of Teladoc Health and Avantor.
